IPS, the developer of a catheter-based procedure for treating lung diseases, has named Dennis Wahr president and CEO, according to a Sept. 20 announcement. Wahr previously co-founded drug-coated balloon angioplasty firm Lutonix, serving as president and CEO until CR Bard acquired the company in December 2011. (See Also see "Bard Buys Lutonix For Lead In Race To U.S. Market With Drug-Coated Balloon" - Medtech Insight, 2 January, 2012..) He was also the founder, president and CEO of Velocimed, maker of a patent foramen ovale closure system, which was acquired by St. Jude Medical in 2005. (See Also see "St. Jude PFO Program For Stroke, Migraine Gets Boost With Velocimed Deal" - Medtech Insight, 21 February, 2005..)
Former president and CEO Steve Dimmer will continue with Innovative Pulmonary Solutions as founder and executive vice president, while co-founder Martin Mayse, an interventional pulmonologist who invented the firm'sTargeted Lung...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?